Kurian S, Novais M, Whisenant T, Gelbart T, Buxbaum J, Kelly J
Theranostics. 2016; 6(11):1792-809.
PMID: 27570551
PMC: 4997237.
DOI: 10.7150/thno.14584.
Ankarcrona M, Winblad B, Monteiro C, Fearns C, Powers E, Johansson J
J Intern Med. 2016; 280(2):177-202.
PMID: 27165517
PMC: 4956553.
DOI: 10.1111/joim.12506.
Coelho T, Merlini G, Bulawa C, Fleming J, Judge D, Kelly J
Neurol Ther. 2016; 5(1):1-25.
PMID: 26894299
PMC: 4919130.
DOI: 10.1007/s40120-016-0040-x.
Lai H, Chiang Y, Yang C, Hsieh S, Chao C, Lee M
PLoS One. 2015; 10(11):e0141935.
PMID: 26529114
PMC: 4631457.
DOI: 10.1371/journal.pone.0141935.
Pickhardt M, Neumann T, Schwizer D, Callaway K, Vendruscolo M, Schenk D
Curr Alzheimer Res. 2015; 12(9):814-28.
PMID: 26510979
PMC: 4976804.
DOI: 10.2174/156720501209151019104951.
Targeting protein aggregation for the treatment of degenerative diseases.
Eisele Y, Monteiro C, Fearns C, Encalada S, Wiseman R, Powers E
Nat Rev Drug Discov. 2015; 14(11):759-80.
PMID: 26338154
PMC: 4628595.
DOI: 10.1038/nrd4593.
Personalized medicine approach for optimizing the dose of tafamidis to potentially ameliorate wild-type transthyretin amyloidosis (cardiomyopathy).
Cho Y, Baranczak A, Helmke S, Teruya S, Horn E, Maurer M
Amyloid. 2015; 22(3):175-80.
PMID: 26193961
PMC: 4549186.
DOI: 10.3109/13506129.2015.1063485.
In vivo detection of nerve injury in familial amyloid polyneuropathy by magnetic resonance neurography.
Kollmer J, Hund E, Hornung B, Hegenbart U, Schonland S, Kimmich C
Brain. 2014; 138(Pt 3):549-62.
PMID: 25526974
PMC: 4339768.
DOI: 10.1093/brain/awu344.
Quantification of transthyretin kinetic stability in human plasma using subunit exchange.
Rappley I, Monteiro C, Novais M, Baranczak A, Solis G, Wiseman R
Biochemistry. 2014; 53(12):1993-2006.
PMID: 24661308
PMC: 3977577.
DOI: 10.1021/bi500171j.
Hydrogen-bond network and pH sensitivity in human transthyretin.
Yokoyama T, Mizuguchi M, Nabeshima Y, Kusaka K, Yamada T, Hosoya T
J Synchrotron Radiat. 2013; 20(Pt 6):834-7.
PMID: 24121323
PMC: 3795539.
DOI: 10.1107/S090904951302075X.
AG10 inhibits amyloidogenesis and cellular toxicity of the familial amyloid cardiomyopathy-associated V122I transthyretin.
Penchala S, Connelly S, Wang Y, Park M, Zhao L, Baranczak A
Proc Natl Acad Sci U S A. 2013; 110(24):9992-7.
PMID: 23716704
PMC: 3683741.
DOI: 10.1073/pnas.1300761110.
Aromatic sulfonyl fluorides covalently kinetically stabilize transthyretin to prevent amyloidogenesis while affording a fluorescent conjugate.
Grimster N, Connelly S, Baranczak A, Dong J, Krasnova L, Sharpless K
J Am Chem Soc. 2013; 135(15):5656-68.
PMID: 23350654
PMC: 3630275.
DOI: 10.1021/ja311729d.
Tafamidis, a potent and selective transthyretin kinetic stabilizer that inhibits the amyloid cascade.
Bulawa C, Connelly S, Devit M, Wang L, Weigel C, Fleming J
Proc Natl Acad Sci U S A. 2012; 109(24):9629-34.
PMID: 22645360
PMC: 3386102.
DOI: 10.1073/pnas.1121005109.
The transthyretin amyloidoses: from delineating the molecular mechanism of aggregation linked to pathology to a regulatory-agency-approved drug.
Johnson S, Connelly S, Fearns C, Powers E, Kelly J
J Mol Biol. 2012; 421(2-3):185-203.
PMID: 22244854
PMC: 3350832.
DOI: 10.1016/j.jmb.2011.12.060.
Transthyretin-related familial amyloidotic polyneuropathy-Progress in Kumamoto, Japan (1967-2010)-.
Araki S, Ando Y
Proc Jpn Acad Ser B Phys Biol Sci. 2010; 86(7):694-706.
PMID: 20689228
PMC: 3066541.
DOI: 10.2183/pjab.86.694.
Quantification of the thermodynamically linked quaternary and tertiary structural stabilities of transthyretin and its disease-associated variants: the relationship between stability and amyloidosis.
Hurshman Babbes A, Powers E, Kelly J
Biochemistry. 2008; 47(26):6969-84.
PMID: 18537267
PMC: 2667099.
DOI: 10.1021/bi800636q.
Fourier transform infrared spectroscopy provides a fingerprint for the tetramer and for the aggregates of transthyretin.
Cordeiro Y, Kraineva J, Suarez M, Tempesta A, Kelly J, Silva J
Biophys J. 2006; 91(3):957-67.
PMID: 16698785
PMC: 1563765.
DOI: 10.1529/biophysj.106.085928.
Liver transplantation and new therapeutic approaches for familial amyloidotic polyneuropathy (FAP).
Ando Y
Med Mol Morphol. 2005; 38(3):142-54.
PMID: 16170462
DOI: 10.1007/s00795-005-0288-1.
Argpyrimidine, a methylglyoxal-derived advanced glycation end-product in familial amyloidotic polyneuropathy.
Gomes R, Silva M, Quintas A, Cordeiro C, Freire A, Pereira P
Biochem J. 2004; 385(Pt 2):339-45.
PMID: 15281912
PMC: 1134703.
DOI: 10.1042/BJ20040833.
Dissociation of amyloid fibrils of alpha-synuclein and transthyretin by pressure reveals their reversible nature and the formation of water-excluded cavities.
Foguel D, Suarez M, Ferrao-Gonzales A, Porto T, Palmieri L, Einsiedler C
Proc Natl Acad Sci U S A. 2003; 100(17):9831-6.
PMID: 12900507
PMC: 187855.
DOI: 10.1073/pnas.1734009100.